Fred and Pamela Buffett Cancer Center — Omaha, Nebraska

Fred and Pamela Buffett Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68198.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Fred and Pamela Buffett Cancer Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Graft-versus-host-disease, Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy.

Sponsors: Incyte Corporation, Curis, Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fred and Pamela Buffett Cancer Center?

Fred and Pamela Buffett Cancer Center has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fred and Pamela Buffett Cancer Center conducted?

Fred and Pamela Buffett Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Graft-versus-host-disease, Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy.

Is Fred and Pamela Buffett Cancer Center accredited by Crixeo Health?

Fred and Pamela Buffett Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fred and Pamela Buffett Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.